Oaktree Specialty Lending Corporation (OCSL)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Armen Panossian J.D. | CEO & Chief Investment Officer | -- | -- | 1976 |
| Mr. Mathew M. Pendo | President | -- | -- | 1964 |
| Mr. Aman Kumar | Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending | -- | -- | -- |
| Mr. Raghav Khanna | Managing Director & Co-Portfolio Manager | -- | -- | 1984 |
| Mr. Christopher McKown | MD,CFO & Treasurer | -- | -- | 1982 |
| Mr. Matthew Stewart C.F.A., C.P.A. | MD & COO | -- | -- | 1985 |
| Mr. Michael Mosticchio | Investor Relations | -- | -- | -- |
| Ms. Mary Gallegly | MD,General Counsel & Secretary | -- | -- | -- |
| Ms. Ashley Pak | Chief Compliance Officer | -- | -- | 1978 |
| Mr. Sandeep Kumar Khorana | Managing Director of Origination | -- | -- | 1973 |
Oaktree Specialty Lending Corporation
- Sector:
- Financial Services
- Industry: Credit Services
Description
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Corporate Governance
Recent Events
- Mar 29, 2024Dividend Date
- Mar 14, 2024Ex-Dividend Date
- Mar 05, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 13, 202440-APP: Applications under the Investment Company Act other than those reviewed by Office of Insurance ProductsSee Full Filing
- Feb 01, 20248-K: Corporate Changes & Voting MattersSee Full Filing